PITTSBURGH — Mylan will begin selling a generic drug for treating symptoms of menopause in two years, the company said Monday. Following the settlement of a patent-litigation suit with Swiss drug ...
Estradiol 0.025mg/day, 0.0375mg/day, 0.05mg/day, 0.075mg/day, 0.1mg/day; transdermal system. Increased risk of endometrial carcinoma or hyperplasia in women with intact uterus (adding progestin is ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Mylan Inc. (Nasdaq: MYL) said Monday it will begin to ...
Nov. 10, 2004 — The U.S. Food and Drug Administration (FDA) approved in August revisions to drug safety labeling to advise healthcare professionals of the following changes: estradiol transdermal ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved a 33% smaller dose of the estradiol transdermal system for the prevention of postmenopausal ...
NEW YORK — A patch for treating menopause that the manufacturer calls the smallest is now available. Noven Pharmaceuticals announced the availability of Minivelle (estradiol) transdermal system in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results